Public Profile

KVK-TECH, Inc.

KVK-TECH, Inc., headquartered in the United States, is a prominent player in the biotechnology and pharmaceutical industry, specialising in the development and manufacturing of high-quality injectable products. Founded in 2005, the company has achieved significant milestones, including the expansion of its operational footprint across North America and Europe. KVK-TECH is renowned for its innovative approach to sterile compounding and its commitment to quality, offering a diverse range of products that cater to the needs of healthcare providers. Their unique formulations and advanced manufacturing processes set them apart in a competitive market. With a strong focus on compliance and safety, KVK-TECH has established itself as a trusted partner in the healthcare sector, consistently delivering reliable solutions that enhance patient care.

DitchCarbon Score

How does KVK-TECH, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

KVK-TECH, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

KVK-TECH, Inc.'s reported carbon emissions

KVK-TECH, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that KVK-TECH may still be in the early stages of formalising its climate commitments or reporting its emissions. As the industry increasingly prioritises sustainability, it is essential for companies like KVK-TECH to establish clear targets and strategies to address their carbon footprint and contribute to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. KVK-TECH, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for KVK-TECH, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

KVK-TECH, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Alvogen, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Mallinckrodt Inc. (Delaware)

US
Updated 6 days ago
DitchCarbon Score

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Aurobindo Pharma

IN
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers